New findings from the CITF-funded SUCCEED project, published in The Lancet Rheumatology, indicate that two doses of mRNA vaccines were 79 to 89% effective at preventing SARS-CoV-2 infection in individuals living with immune-mediated inflammatory diseases in Ontario.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed